{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:09:20Z","timestamp":1790140160475,"version":"4.0.1"},"reference-count":30,"publisher":"The Pediatric Pharmacy Association","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,1]]},"abstract":"<jats:p>Patent ductus arteriosus (PDA) is the failure of the ductus that arises from the distal dorsal aortic arch to close during the first few days of life. The treatment options for PDA include \u201cwatchful waiting,\u201d pharmacologic therapy with cyclooxygenase (COX) inhibitors (COX-1 and COX-2), such as indomethacin or intravenous (IV) ibuprofen lysine, and surgery when medical interventions have proved ineffective. The clinical trials evaluating the utilization of IV ibuprofen lysine focus on either preventing the persistence of a PDA or treating the PDA in premature infants in whom the ductus does not close within 48 hours of birth. Although the role of COX inhibitors in prophylaxis of PDA has been studied, it has not been clearly delineated. Treatment of PDA in preterm low birth weight infants from the second day of life on with IV ibuprofen lysine has been studied in 4 major and 3 smaller clinical trials. Overall, in 7 studies with 492 patients, the closure rate of PDA was 75.1% with IV ibuprofen lysine compared to 73.5% with indomethacin. In addition, neonates treated with IV ibuprofen lysine had significantly better creatinine clearance, urine output, serum creatinine, and blood urea nitrogen (BUN) profiles than indomethacin-treated patients. Overall, IV ibuprofen lysine is as effective as indomethacin for closure of PDA, yet is associated with a better safety profile with fewer negative side effects when compared to indomethacin.<\/jats:p>","DOI":"10.5863\/1551-6776-12.3.171","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T20:11:07Z","timestamp":1603829467000},"page":"171-182","source":"Crossref","is-referenced-by-count":1,"title":["Clinical Experience with Intravenous Ibuprofen Lysine in the Pharmacologic Closure of Patent Ductus Arteriosus"],"prefix":"10.5863","volume":"12","author":[{"given":"Evelyn R.","family":"Hermes-DeSantis","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob V.","family":"Aranda","sequence":"additional","affiliation":[{"name":"Pediatric Pharmacology Research Unit Network, Children's Hospital of Michigan, Detroit, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3883","reference":[{"issue":"1","key":"i1551-6776-12-3-171-b1","series-title":"Cochrane Database Syst Rev","article-title":"Ibuprofen for the prevention of patent ductus arteriosus in preterm and\/or low birth weight infants","year":"2006","unstructured":"Shah\n              SS\n            , OhlssonA.\n          Ibuprofen for the prevention of patent ductus arteriosus in preterm and\/or low birth weight infants. Cochrane Database Syst Rev2006,(1):CD004213.pub2."},{"key":"i1551-6776-12-3-171-b2","series-title":"Pediatr Res","first-page":"36","article-title":"Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus","volume":"47","year":"2000","unstructured":"Patel\n              J\n            , RobertsI, AzzopardiD, et al. Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatr Res2000;47:36\u201342."},{"key":"i1551-6776-12-3-171-b3","series-title":"J Pediatr","first-page":"647","article-title":"Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants","volume":"93","year":"1978","unstructured":"Cotton\n              RB\n            , StahlmanMT, BenderHW, et al. Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. J Pediatr1978;93:647\u2013651."},{"key":"i1551-6776-12-3-171-b4","series-title":"J Pediatr","first-page":"682","article-title":"Improved lung compliance after ligation of patient ductus arteriosus in hyaline membrane disease","volume":"93","year":"1978","unstructured":"Naulty\n              CM\n            , HornS, ConryJ, et al. Improved lung compliance after ligation of patient ductus arteriosus in hyaline membrane disease. J Pediatr1978;93:682\u2013684."},{"key":"i1551-6776-12-3-171-b5","series-title":"Pediatrics","first-page":"1070","article-title":"Variations in practice and outcomes in the Canadian NICU network: 1996\u20131997","volume":"106","year":"2000","unstructured":"Lee\n              SK\n            , McMillanDD, OhlssonA, PendrayM, SynnesA, WhyteR, et al. Variations in practice and outcomes in the Canadian NICU network: 1996\u20131997. Pediatrics2000;106:1070\u20131079."},{"key":"i1551-6776-12-3-171-b6","series-title":"N Engl J Med","first-page":"526","article-title":"Pharmacologic closure of patent ductus arteriosus in the premature infant","volume":"295","year":"1976","unstructured":"Friedman\n              WF\n            , HirschklauMJ, PrintzMP, et al. Pharmacologic closure of patent ductus arteriosus in the premature infant. N Engl J Med1976;295:526\u2013529."},{"issue":"4","key":"i1551-6776-12-3-171-b7","series-title":"Cochrane Database Syst Rev","article-title":"Ibuprofen for the treatment of patent ductus arteriosus in preterm and\/or low birth weight infants","year":"2005","unstructured":"Ohlsson\n              A\n            , WaliaR, ShahS.\n          Ibuprofen for the treatment of patent ductus arteriosus in preterm and\/or low birth weight infants. Cochrane Database Syst Rev2005,(4):CD003481.pub2."},{"key":"i1551-6776-12-3-171-b8","series-title":"J Pediatr","first-page":"895","article-title":"Effects of indomethacin in premature infants with patent ductus arteriosus: Results of a national collaborative study","volume":"102","year":"1983","unstructured":"Gersony\n              WM\n            , PeckhamGJ, EllisonRC, et al. Effects of indomethacin in premature infants with patent ductus arteriosus: Results of a national collaborative study. J Pediatr1983;102:895\u2013905."},{"key":"i1551-6776-12-3-171-b9","series-title":"N Engl J Med","first-page":"674","article-title":"A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus","volume":"343","year":"2000","unstructured":"Van Overmeire\n              B\n            , SmetsK, LecoutereD, et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med2000;343:674\u2013681."},{"key":"i1551-6776-12-3-171-b10","series-title":"Eur J Pediatr","first-page":"202","article-title":"Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial","volume":"161","year":"2002","unstructured":"Lago\n              P\n            , BettiolT, SalvadoriS, et al. Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial. Eur J Pediatr2002;161:202\u2013207."},{"key":"i1551-6776-12-3-171-b11","series-title":"Arch Dis Child Fetal Neonatal Ed","first-page":"179","article-title":"Treatment of patent ductus arteriosus with ibuprofen","volume":"76","year":"1997","unstructured":"Van Overmeire\n              B\n            , FollensI, HartmannS, et al. Treatment of patent ductus arteriosus with ibuprofen. Arch Dis Child Fetal Neonatal Ed1997;76:179\u2013184."},{"key":"i1551-6776-12-3-171-b12","series-title":"Eur J Pediatr","first-page":"135","article-title":"A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus","volume":"164","year":"2005","unstructured":"Thomas\n              RL\n            , ParkerGC, Van OvermeireB, et al. A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus. Eur J Pediatr2005;164:135\u2013140."},{"key":"i1551-6776-12-3-171-b13","series-title":"Pediatrics","first-page":"1529","article-title":"Prophylactic ibuprofen for the prevention of intraventricular hemorrhage (IVH) among preterm infants: A multicenter, randomized study","volume":"115","year":"2005","unstructured":"Dani\n              C\n            , BertiniG, PezzatiM, et al. Prophylactic ibuprofen for the prevention of intraventricular hemorrhage (IVH) among preterm infants: A multicenter, randomized study. Pediatrics2005;115:1529\u20131535."},{"key":"i1551-6776-12-3-171-b14","series-title":"J Perinatol","first-page":"S14","article-title":"Patent ductus arteriosus: Pathophysiology and management","volume":"26","year":"2006","unstructured":"Hermes-DeSantis\n              ER\n            , ClymanRI.\n          Patent ductus arteriosus: Pathophysiology and management. J Perinatol2006;26:S14\u2013S18."},{"key":"i1551-6776-12-3-171-b15","series-title":"Drug Information Handbook","first-page":"806","year":"2006\u20132007","unstructured":"Lacy\n              CF\n            , ArmstrongLL, GoldmanMP, et al. Drug Information Handbook, 14th ed. Hudson, OH: Lexi-Comp; 2006\u20132007:806\u2013808."},{"key":"i1551-6776-12-3-171-b16","series-title":"J Clin Pharm Ther","first-page":"121","article-title":"Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method","volume":"30","year":"2005","unstructured":"Desfrere\n              L\n            , ZoharS, MorvilleP, et al. Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method. J Clin Pharm Ther2005;30:121\u2013132."},{"key":"i1551-6776-12-3-171-b17","series-title":"JAMA","first-page":"539","article-title":"Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants","volume":"275","year":"1996","unstructured":"Varvarigou\n              A\n            , BardinCL, BeharryK, et al. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. JAMA1996;275:539\u2013544."},{"key":"i1551-6776-12-3-171-b18","series-title":"Eur J Pediatr","first-page":"364","article-title":"Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants","volume":"159","year":"2000","unstructured":"De Carolis\n              MP\n            , RomagnoliC, PolimeniV, et al. Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants. Eur J Pediatr2000;159:364\u2013368."},{"key":"i1551-6776-12-3-171-b19","series-title":"Lancet","first-page":"1945","article-title":"Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial","volume":"364","year":"2004","unstructured":"Van Overmeire\n              B\n            , AllegaertK, CasaerA, et al. Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet2004;364:1945\u20131949."},{"key":"i1551-6776-12-3-171-b20","series-title":"N Engl J Med","first-page":"1966","article-title":"Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants","volume":"344","year":"2001","unstructured":"Schmidt\n              B\n            , DavisP, ModdemannD, et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med2001;344:1966\u20131972."},{"key":"i1551-6776-12-3-171-b21","series-title":"J Perinatol","first-page":"158","article-title":"Indomethacin prophylaxis or expectant treatment of patent ductus arteriosus in extremely low birth weight infants?","volume":"27","year":"2007","unstructured":"Cordero\n              L\n            , NankervisCA, DeLoozeD, et al. Indomethacin prophylaxis or expectant treatment of patent ductus arteriosus in extremely low birth weight infants?J Perinatol2007, 27:158\u2013163."},{"key":"i1551-6776-12-3-171-b22","series-title":"Lancet","first-page":"1939","article-title":"Prophylactic ibuprofen versus placebo in very premature infants: A randomised, double-blind, placebo-controlled trial","volume":"364","year":"2004","unstructured":"Gournay\n              V\n            , RozeJC, KusterA, et al. Prophylactic ibuprofen versus placebo in very premature infants: A randomised, double-blind, placebo-controlled trial. Lancet2004;364:1939\u20131944."},{"key":"i1551-6776-12-3-171-b23","series-title":"Pediatr Int","first-page":"665","article-title":"Comparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants","volume":"45","year":"2003","unstructured":"Su\n              P-H\n            , ChenJ-Y, SuC-M, et al. Comparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants. Pediatr Int2003;45:665\u2013670."},{"key":"i1551-6776-12-3-171-b24","series-title":"J Pediatr","first-page":"549","article-title":"Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus","volume":"131","year":"1997","unstructured":"Mosca\n              F\n            , BrayM, LattanzioM, et al. Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. J Pediatr1997;131:549\u2013554."},{"key":"i1551-6776-12-3-171-b25","series-title":"J Pediatr","first-page":"733","article-title":"Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus","volume":"135","year":"1999","unstructured":"Pezzati\n              M\n            , VangiV, BiagiottiR, et al. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J Pediatr1999;135:733\u2013738."},{"key":"i1551-6776-12-3-171-b26","series-title":"Semin Perinatol","first-page":"114","article-title":"Systematic review: intravenous ibuprofen in preterm newborns","volume":"30","year":"2006","unstructured":"Aranda\n              JV\n            , ThomasR.\n          Systematic review: intravenous ibuprofen in preterm newborns. Semin Perinatol2006;30:114\u2013120."},{"key":"i1551-6776-12-3-171-b27","series-title":"NeoProfen (ibuprofen lysine) package insert","year":"May 2006","unstructured":"Ovation Pharmaceuticals. NeoProfen (ibuprofen lysine) package insert. Deerfield, IL; May 2006."},{"key":"i1551-6776-12-3-171-b28","series-title":"Lancet","first-page":"255","article-title":"Ibuprofen treatment of patent ductus arteriosus","volume":"346","year":"1995","unstructured":"Patel\n              J\n            , MarksKA, RobertsI, et al. Ibuprofen treatment of patent ductus arteriosus. Lancet1995;346:255."},{"key":"i1551-6776-12-3-171-b29","series-title":"CMAJ","first-page":"1843","article-title":"Pulmonary hypertension following L-lysine ibuprofen therapy in a preterm infant with patent ductus arteriosus","volume":"174","year":"2006","unstructured":"Bellini\n              C\n            , CamponeF, SerraG.\n          Pulmonary hypertension following L-lysine ibuprofen therapy in a preterm infant with patent ductus arteriosus. CMAJ2006;174:1843\u20131844."},{"key":"i1551-6776-12-3-171-b30","series-title":"J Pediatr","first-page":"632","article-title":"Pretreatment cortisol values may predict responses to hydrocortisone administration for the prevention of bronchopulmonary dysplasia in high-risk infants","volume":"146","year":"2005","unstructured":"Peltoniem\n              IO\n            , KariMA, HeinonenK, et al. Pretreatment cortisol values may predict responses to hydrocortisone administration for the prevention of bronchopulmonary dysplasia in high-risk infants. J Pediatr2005;146:632\u2013637."}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"link":[{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/12\/3\/article-p171.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/jppt\/article-pdf\/12\/3\/171\/1783112\/1551-6776-12_3_171.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/12\/3\/article-p171.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/12\/3\/article-p171.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:49:12Z","timestamp":1747356552000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/12\/3\/article-p171.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":30,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-12.3.171","relation":{},"ISSN":["1551-6776"],"issn-type":[{"value":"1551-6776","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}